Gapping up
In reaction to strong earnings/guidance: TFM +10.1%, BORN +7.9%, TIVO+6%, GME +4.2%, ORIG +3.8%, NWY +3.2%, NDSN +2.6%, FL +2.3%, BRCD+1.5%, ZUMZ +0.9%, AMAP +0.5%.
DDD +1.4% following Fast Money mention and related names showing strength: XONE 2.3%, DDD 1.4%, SSYS 0.5%.
Other news: PTCT +131.7% (receives positive opinion from CHMP for Translarn),FLTX +38.9% (still checking), RNA +11.8% (in sympathy with PTCT), ZIOP +9% (announces oral presentation highlighting Ad-RTS-IL-12 results correlated with reducing cancer stem cells in the brain at ASGCT 17th Annual Meeting ), OWW+5.2% (prices 7.5 mln shares of its common stock held by Selling Stockholder, at $6.60 per share), ISIS +5% (Hearing positive comments at Piper Jaffray--suggesting may have best pipeline), GTAT +4% (ticking higher on story suggesting Samsung (SSNLF) use of sapphire display technology), WAVX +2.2% (positive Mad Money mention), ALU +1.9% (reports of Thales unit sale), TMUS +1.3% (reports suggesting TMUS overtook Sprint (S) as #3 mobile carrier), TXRH +1.2% (approves stock repurchase for up to $100.0 mln of co's common stock), BIIB+1.1% (CHMP adopts Positive Opinion for PLEGRIDY as a treatment for multiple sclerosis in EU), JD +1% (recent IPO, positive Mad Money mention), NAVI +0.8% (announced $400 mln share repurchase program; declares $0.15 per share dividend), WFM +0.6% (following TFM results; Regional President discloses purchase of 13,686 shares at $37.44), CAB +0.5% (positve Mad Money mention).
Analyst comments: FEYE +2.9% (upgraded to Overweight from Equal-weight at Barclays), RBCN +1.7% (upgraded to Perform from Underperform at Oppenheimer), LB +0.8% (upgraded upgraded to Buy from Hold at Stifel)
DDD +1.4% following Fast Money mention and related names showing strength: XONE 2.3%, DDD 1.4%, SSYS 0.5%.
Other news: PTCT +131.7% (receives positive opinion from CHMP for Translarn),FLTX +38.9% (still checking), RNA +11.8% (in sympathy with PTCT), ZIOP +9% (announces oral presentation highlighting Ad-RTS-IL-12 results correlated with reducing cancer stem cells in the brain at ASGCT 17th Annual Meeting ), OWW+5.2% (prices 7.5 mln shares of its common stock held by Selling Stockholder, at $6.60 per share), ISIS +5% (Hearing positive comments at Piper Jaffray--suggesting may have best pipeline), GTAT +4% (ticking higher on story suggesting Samsung (SSNLF) use of sapphire display technology), WAVX +2.2% (positive Mad Money mention), ALU +1.9% (reports of Thales unit sale), TMUS +1.3% (reports suggesting TMUS overtook Sprint (S) as #3 mobile carrier), TXRH +1.2% (approves stock repurchase for up to $100.0 mln of co's common stock), BIIB+1.1% (CHMP adopts Positive Opinion for PLEGRIDY as a treatment for multiple sclerosis in EU), JD +1% (recent IPO, positive Mad Money mention), NAVI +0.8% (announced $400 mln share repurchase program; declares $0.15 per share dividend), WFM +0.6% (following TFM results; Regional President discloses purchase of 13,686 shares at $37.44), CAB +0.5% (positve Mad Money mention).
Analyst comments: FEYE +2.9% (upgraded to Overweight from Equal-weight at Barclays), RBCN +1.7% (upgraded to Perform from Underperform at Oppenheimer), LB +0.8% (upgraded upgraded to Buy from Hold at Stifel)